Table 2 Biomarkers of female and male COVID-19 patients and controls as reported in SDY1648
Gene ID | Gene Name | Significant Difference between Diseased & Healthy in the Same Sexa | Significant Difference in Female/male Patienta After Adjustments | Significant Difference in Female/male in Healtha After Adjustments |
|---|---|---|---|---|
1435 | CSF1 colony stimulation factor 1 | Both | - (Female) | - (Female) |
1440 | CSF3 colony stimulating factor 3 | Female | - (Male) | - (Male) |
3440 | IFNa2 interferon alpha2 | Both | - (Female) | - (Male) |
3458 | IFNG interferon gamma | Female | - (Female) | - (Male) |
3557 | IL-1RA interleukin 1 receptor antagonist | Both | - (Male) | - (Male) |
3569 | IL-6 Interleukin-6 | Both | - (Male) | - (Female) |
3606 | IL-18 Interleukin-18 | Female | - (Male) | - (Male) |
3576 | CXCL8 (IL8) C-X-C motif chemokine ligand 8 | Female | - (Male) | - (Female) |
3627 | CXCL10 C-X-C motif chemokine ligand 10 | Both | - (Male) | - (Female) |
6351 | CCL4 C-C motif chemokine ligand 4 | Male | - (Male) | - (Female) |
6352 | CCL5 C-C motif chemokine ligand 5 | Both | - (Male) | - (Female) |